HSD73 Neoadjuvant Adjuvant Therapy for Early-Stage/Resectable Non-Small Cell Lung Cancer (NSCLC): Physician Practices, Therapy Choice, and Challenges Among US Oncologists
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1296
https://www.valueinhealthjournal.com/article/S1098-3015(24)01411-6/fulltext
Title :
HSD73 Neoadjuvant Adjuvant Therapy for Early-Stage/Resectable Non-Small Cell Lung Cancer (NSCLC): Physician Practices, Therapy Choice, and Challenges Among US Oncologists
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01411-6&doi=10.1016/j.jval.2024.03.1296
First page :
Section Title :
Open access? :
No
Section Order :
10688